Ron Kocak - 09 Feb 2024 Form 3 Insider Report for RenovoRx, Inc. (RNXT)

Role
VP, Controller and PAO
Signature
/s/ Ronald Kocak
Issuer symbol
RNXT
Transactions as of
09 Feb 2024
Net transactions value
$0
Form type
3
Filing time
12 Feb 2024, 19:39:28 UTC
Next filing
10 Apr 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding RNXT Options 09 Feb 2024 Common Stock 34,390 $2.19 Direct F1
holding RNXT Options 09 Feb 2024 Common Stock 15,875 $3.29 Direct F2
holding RNXT Options 09 Feb 2024 Common Stock 3,000 $2.11 Direct F3
holding RNXT Non-Qualified Stock Option 09 Feb 2024 Common Stock 12,248 $1.08 Direct F4
holding RNXT Options 09 Feb 2024 Common Stock 48,128 $1.08 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents 10-year incentive stock options granted to the reporting person on August 18,2022 pursuant to Company's 2021 Omnibus Equity Incentive Plan (the "Plan"). These options vest at a rate of 1/48 per month beginning on the grant date.
F2 Represents 10-year incentive stock options granted to the reporting person on March 15, 2023 pursuant to the Plan. These vest at a rate of 1/48 per month beginning on the grant date.
F3 Represents 10-year incentive stock options granted to the reporting person on June 1, 2023 pursuant to the Plan. These options vest at a rate of 1/48 per month beginning on the grant date.
F4 Represents 10-year stock non-qualified stock options granted to the reporting person on January 19, 2024 pursuant to the Plan. These options vest at a rate of 1/48 per month beginning on February 1, 2024.
F5 Represents 10-year stock incentive stock options granted to the reporting person on January 19, 2024 pursuant to the Plan as a bonus. These options were fully vested upon issuance.